Valbiotis S.A.
ALVAL.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €0 | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €0 | €0 | €0 | €0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | -96.3% | 502.9% | 163.4% | – |
| Gross Profit | -€0 | €0 | €0 | €0 |
| % Margin | -1,396% | 56.8% | 97.7% | 94.6% |
| EBITDA | -€0 | -€0 | -€0 | -€0 |
| % Margin | -5,241.1% | -135.5% | -1,418.3% | -3,067.8% |
| Net Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | -5,728.6% | -155.7% | -1,568.4% | -2,913.1% |
| EPS Diluted | -0.63 | -0.59 | -1.22 | -0.95 |
| % Growth | -6.8% | 51.6% | -28.4% | – |
| Operating Cash Flow | -€0 | -€0 | -€0 | -€0 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | -€0 | -€0 | -€0 | -€0 |